Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial

Respiratory Medicine

Volumn 98, Issue 9, 2004, Pages 906-913

  Svartberg, Johan ^a   Aaseboo U ^a   Hjalmarsen, A ^a   Sundsfjord, J ^a   Jorde, R ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Body composition; Chronic obstructive pulmonary disease; Erectile dysfunction; Fat mass; Fat free mass; Pulmonary function; Quality of life; Sexuality; Testosterone treatment

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCOCORTICOID; IPRATROPIUM BROMIDE; OXYGEN; PREDNISONE; STEROID; TESTOSTERONE; TESTOSTERONE ENANTATE; THEOPHYLLINE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; LEAN BODY WEIGHT; LOW DRUG DOSE; LUNG FUNCTION TEST; MALE; MALE SEXUAL DYSFUNCTION; MEDICAL ASSESSMENT; PENIS ERECTION; PNEUMONIA; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUALITY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TESTOSTERONE BLOOD LEVEL; TREATMENT PLANNING;

ADIPOSE TISSUE; AGED; BODY COMPOSITION; DENSITOMETRY, X-RAY; DRUG ADMINISTRATION SCHEDULE; HUMANS; INJECTIONS, INTRAMUSCULAR; LUNG; MALE; MIDDLE AGED; PENILE ERECTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; TESTOSTERONE;

EID: 4043104928     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2004.02.015     Document Type: Article

References (34)

1. Nocturnal Oxygen Therapy Trial Group. Continous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease. Ann Intern Med 1980 93 391-8
2. ATS Statement. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995 152 S77-121
3. Casaburi R. Porszasz J. Burns M.R. Carithers E.R. Chang R.S. Cooper C.B. Physiologic benefits of exercise training in rehabilitation of severe COPD patients Am J Respir Crit Care Med 155 1997 1541-1551
4. Rochester D.F. Malnutrition and the respiratory muscles Clin Chest Med 7 1986 91-99
5. ZuWallack R.L. Shoup R. Warner S. Davies M. Khan F. Dalsky G. Alterations in total and regional body composition in patients with moderate to severe obstructive lung disease Monaldi Arch Chest Dis 51 1996 507-509
6. Rogers R.M. Donahoe M. Costantino J. Physiological effects of oral supplemental feeding in malnourished patients with chronic obstructive pulmonary disease. A randomized control study Am Rev Respir Dis 246 1992 1511-1517
7. Schols A.M. Slangen J. Volovics L. Wouters E.F. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 1791-1797
8. Kamischke A. Kemper D.E. Castel M.A. et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy Eur Respir J 11 1998 41-45
9. Aasebo U. Gyltnes A. Bremnes R.M. Aakvaag A. Slørdal L. Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy J Steroid Biochem Mol Biol 46 1993 799-803
10. Tenover J.S. Testosterone replacement therapy in older adult men Int J Androl 22 1999 300-306
11. Morley J.E. Androgens and aging Maturitas 38 2001 61-73
12. Basaria S. Dobs A.S. Hypogonadism and androgen replacement therapy in elderly men Am J Med 110 2001 563-572
13. Schols A.M. Soeters P.B. Mostert R. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 1995 1268-1274
14. Ferreira I.M. Verreschi I.T. Nery L.E. et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients Chest 114 1998 19-28
15. Vermeulen A. Verdonck L. Kaufman J.M. A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666-3672
16. Jones P.W. Quirk F.H. Baveystock C.M. Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire Am Rev Respir Dis 145 1992 1321-1327
17. Montgomery S.A. Asberg M. A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382-389
18. Rosen R.C. Cappelleri J.C. Smith M.D. Lipsky J. Pena B.M. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction Int J Impot Res 11 1999 319-326
19. Linn M.W. Linn B.S. The rapid disability rating scale-2 J Am Geriatr Soc 30 1982 378-382
20. Folstein M.F. Folstein S.E. McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189-198
21. Helkala E.L. Kivipelto M. Hallikainen M. et al. Usefulness of repeated presentation of mini-mental state examination as a diagnostic procedure - a population-based study Acta Neurol Scand 106 2002 341-346
22. Bhasin S. Storer T.W. Berman N. et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men N Engl J Med 335 1996 1-7
23. Bhasin S. Storer T.W. Berman N. et al. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men J Clin Endocrinol Metab 82 1997 407-413
24. Snyder P.J. Peachey H. Hannoush P. et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age J Clin Endocrinol Metab 84 1999 2647-2653
25. Snyder P.J. Peachey H. Berlin J.A. et al. Effects of testosterone replacement in hypogonadal men J Clin Endocrinol Metab 85 2000 2670-2677
26. Semple P.D. Beastall G.H. Watson W.S. Hume R. Serum testosterone depression associated with hypoxia in respiratory failure Clin Sci 58 1980 105-106
27. Semple P.D. Beastall G.H. Watson W.S. Hume R. Hypothalamic-pituitary dysfunction in respiratory hypoxia Thorax 36 1981 605-609
28. Monga M. Kostelec M. Kamarei M. Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction Arch Androl 48 2002 433-442
29. Rhoden E.L. Teloken C. Mafessoni R. Souto C.A. Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction? Int J Impot Res 14 2002 167-171
30. Sih R. Morley J.E. Kaiser F.E. Perry 3rd H.M. Patrick P. Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial J Clin Endocrinol Metab 82 1997 1661-1667
31. Hajjar R.R. Kaiser F.E. Morley J.E. Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis J Clin Endocrinol Metab 82 1997 3793-3796
32. Dobs A.S. Meikle A.W. Arver S. Sanders S.W. Caramelli K.E. Mazer N.A. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men J Clin Endocrinol Metab 84 1999 3469-3478
33. Matsumoto A.M. Sandblom R.E. Schoene R.B. et al. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoes, respiratory drives, and sleep Clin Endocrinol 22 1985 713-721
34. Tenover J.L. Effects of androgen supplementation in aging males In: Oddens B. Vermeulen A. editors. Androgens and the aging male 1996 191-204 Parthenon Publishing Group New York, London